Kim, H. R., Oberoi, A., Lopez, J. S., El-Khoueiry, A. B., Saavedra, O., Thomas, J. S., Rogowski, W., Boni, V., Szczylik, C., Cervantes, A., Lugowska, I. A., Ramlau, R., Christenson, E. S., Shim, B. Y., Garassino, M. C., Gärtner, U., Schütz, D., Pietzko, K., Emig, M., Morales-Espinosa, D. (2025). Bispecific innate cell engager (ICE) AFM24 in combination with atezolizumab in patients with advanced/metastatic EGFR -expressing non-small cell lung cancer (NSCLC) without driver mutations: Initial results from a phase 2a study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2609